← Back to Bills
HR 9141118th CongressFailed / ExpiredHouse

IVF with HSAs Act of 2024

Policy Area: Taxation
View on Congress.gov
Origin Chamber
House
Last Updated
Dec 19, 2024
Latest Action Date
Dec 17, 2024

Latest Action

Referred to the Subcommittee on Health.

Official Summary

Official summary has not been imported yet.

GovScope Watchdog™

AI Government Intelligence™
Executive Summary

The IVF with HSAs Act of 2024 is a bill introduced in the 118th Congress aimed at modifying tax policy related to Health Savings Accounts (HSAs). Although the official summary and full text are not available, the bill's title suggests it seeks to allow or expand the use of HSAs for expenses related to in vitro fertilization (IVF). The bill was referred to the House Subcommittee on Health but ultimately failed or expired without further legislative action.

Bottom Line

This bill intended to change tax rules to potentially allow HSA funds to be used for IVF treatments, but it did not advance beyond subcommittee referral and expired in the 118th Congress.

Policy Risk Level
🟡 Medium
Neutral Risk Assessment
Key Points
  • The bill is related to taxation policy, specifically concerning Health Savings Accounts (HSAs).
  • It was introduced in the House during the 118th Congress and referred to the Subcommittee on Health.
  • No official summary or full text is publicly available, and the bill status is 'Failed / Expired'.
Who Benefits?

['Individuals seeking to use Health Savings Accounts for IVF-related medical expenses', 'Healthcare providers offering IVF treatments', 'Taxpayers who utilize HSAs and may benefit from expanded allowable expenses']

Potential Concerns

['Lack of publicly available full bill text limits detailed understanding of implementation and enforcement mechanisms.', 'Potential fiscal impact on tax revenues due to expanded HSA usage for IVF expenses.', 'Oversight and administration challenges in defining and verifying eligible IVF-related expenses under HSAs.']

Political Context

The bill was introduced in the House during the 118th Congress and referred to the Subcommittee on Health. It did not progress further and expired without becoming law. The policy area is taxation, focusing on the use of HSAs for medical expenses, reflecting ongoing legislative interest in healthcare-related tax benefits.

Hidden Impact Review

Hidden impact flags detected: 2

GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.

2 Detected
Detected Flags
Indirect Effects

['Potential increase in utilization of IVF treatments if HSA funds become available for such expenses.', 'Possible administrative burden on HSA custodians and tax authorities to verify IVF-related expenses.', 'Influence on employer-sponsored health plans and insurance coverage decisions related to fertility treatments.']

GovScope Watchdog Notes

Transparency is limited due to the absence of an official bill summary and full text, restricting comprehensive analysis. The bill's referral to a subcommittee without further action and its expired status indicate limited legislative progress. Fiscal and implementation impacts remain unclear, highlighting the need for detailed cost and operational assessments in future proposals.

Passage Likelihood: LowConfidence: 75%Model: gpt-4.1-mini

GovScope Intelligence Roadmap

Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.

Enterprise Ready